NCT04655391 2022-06-09
Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation
City of Hope Medical Center
Phase 1 Withdrawn
Clinical Trials
6 trialsNCT02782403 2020-11-19
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02058277 2014-06-24
A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers
Pfizer
Phase 1 Completed
NCT01374139 2011-11-30
Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects
Pfizer
Phase 1 Completed
NCT00759837 2009-07-16
Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed
NCT00777530 2008-10-23
Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed